The calpain family of calcium-dependent proteases has been implicated in a variety of diseases and neurodegenerative pathologies. Prolonged activation of
calpains results in proteolysis of numerous cellular substrates including cytoskeletal components and membrane receptors, contributing to cell demise despite coincident expression of calpastatin, the specific inhibitor of calpains. Pharmacological and gene knockout strategies have targeted calpains to determine their contribution to neurodegenerative pathology; however, limitations associated with treatment paradigms, drug specificity, and genetic disruptions have produced inconsistent results and complicated interpretation. Specific, targeted calpain inhibition achieved by enhancing endogenous calpastatin levels offers unique advantages in studying pathological calpain activation. We have characterized a novel calpastatin overexpressing transgenic
mouse model, demonstrating a substantial increase in calpastatin expression within nervous system and peripheral tissues and associated reduction in protease activity. Experimental activation of calpains via traumatic brain injury resulted in cleavage of α-spectrin, collapsin response mediator protein-2, and voltage-gated sodium channel, critical proteins for the maintenance of neuronal structure and function. Calpastatin overexpression significantly attenuated calpain-mediated proteolysis of these selected substrates acutely following severe controlled cortical impact injury, but with no effect on acute hippocampal neurodegeneration. Augmenting calpastatin levels may be an effective method for calpain inhibition in TBI and neurodegenerative disorders.
Brain injury-induced proteolysis is reduced in a novel calpastatin overexpressing transgenic mouse
Creators
Kathleen M. Schoch - University of Kentucky
Catherine R. von Reyn - University of Pennsylvania
Jifeng Bian - Colorado State University
Glenn C. Telling - Colorado State University
David F. Meaney - University of Pennsylvania
Kathryn E. Saatman - University of Kentucky
Publication Details
Journal of neurochemistry, v 125(6), pp 909-920
Publisher
Wiley
Number of pages
12
Grant note
P01 NS056202 || NS / National Institute of Neurological Disorders and Stroke : NINDS
P01 NS058484 || NS / National Institute of Neurological Disorders and Stroke : NINDS
P30 NS051220 || NS / National Institute of Neurological Disorders and Stroke : NINDS
Resource Type
Journal article
Language
English
Academic Unit
School of Biomedical Engineering, Science, and Health Systems
Web of Science ID
WOS:000320041700011
Scopus ID
2-s2.0-84878757431
Other Identifier
991019176802404721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: